Health Care Down, Trimming Gains - Health Care Roundup

Dow Jones04-03

Health-care companies fell, trimming recent gains, as traders rotated into sectors more sensitive to shifts in the geopolitical outlook.

The U.S. will impose tariffs of up to 100% on branded pharmaceuticals, the White House said Thursday, though nations or drugmakers that strike deals with the Trump administration or commit to build manufacturing facilities in the U.S. can receive lower levies.

Eli Lilly pared its gains for the week.

 

Write to Rob Curran at rob.curran@dowjones.com

(END) Dow Jones Newswires

April 02, 2026 17:14 ET (21:14 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment